Evidence map›Paper›PMID 40044697›Full record

ArticleNature communications2025

A fast approach for structural and evolutionary analysis based on energetic profile protein comparison.

Peyman Choopanian, Jaan-Olle Andressoo, Mehdi Mirzaie

Erratum issuedAbstract readComparative Study
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Peyman ChoopanianDepartment of Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.ORCID http://orcid.org/0000-0003-1428-9231
Jaan-Olle Andressoo *Department of Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland. jaan-olle.andressoo@helsinki.fi.ORCID http://orcid.org/0000-0002-0271-3157
Mehdi Mirzaie *Department of Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Mehdi.mirzaie@helsinki.fi.ORCID http://orcid.org/0000-0003-4434-5118

Funding

Academy of Finland (Suomen Akatemia) 297727 and 350678
6 · The paper itself

Abstract

In structural bioinformatics, the efficiency of predicting protein similarity, function, and evolutionary relationships is crucial. Our approach proposed herein leverages protein energy profiles derived from a knowledge-based potential, deviating from traditional methods relying on structural alignment or atomic distances. This method assigns unique energy profiles to individual proteins, facilitating rapid comparative analysis for both structural similarities and evolutionary relationships across various hierarchical levels. Our study demonstrates that energy profiles contain substantial information about protein structure at class, fold, superfamily, and family levels. Notably, these profiles accurately distinguish proteins across species, illustrated by the classification of coronavirus spike glycoproteins and bacteriocin proteins. Introducing a separation measure based on energy profile similarity, our method shows significant correlation with a network-based approach, emphasizing the potential of energy profiles as efficient predictors for drug combinations with faster computational requirements. Our key insight is that the sequence-based energy profile strongly correlates with structure-derived energy, enabling rapid and efficient protein comparisons based solely on sequences.

Indexed as

Computational BiologyEvolution, MolecularProteinsBacteriocinsModels, MolecularProtein ConformationSpike Glycoprotein, CoronavirusThermodynamicsBacteriocinsProteinsSpike Glycoprotein, Coronavirus

Identifiers

PMID40044697
PMCPMC11882786

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.